Revenue +187.1% YoY; operating margin +98.6 pts YoY
Core Scientific · Period ended Sep 30, 2026Sales expanded and a greater share converted to operating profit. Reported operating margin was +31.1%, versus -67.6% a year earlier. Large percentage swings can reflect a small prior-year base, business transitions or exceptional items; inspect the dollar amounts and the filing.